Global Digital Biomarkers Market 2024-2028
The digital biomarkers market is forecasted to grow by USD 4429.71 mn during 2023-2028, accelerating at a CAGR of 21.04% during the forecast period. The report on the digital biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of neurological disorders, the increasing prevalence of CVDs, and the increasing adoption of smart wearables.
Technavio's digital biomarkers market is segmented as below:
By End-user
- Healthcare companies
- Healthcare providers
- Others
By Type
- Wearables
- Mobile application
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing focus on personalized treatments as one of the prime reasons driving the digital biomarkers market growth during the next few years. Also, the increasing number of clinical trials in countries and growing demand for remote health monitoring will lead to a sizable demand in the market.
The report on the digital biomarkers market covers the following areas:
- Digital biomarkers market sizing
- Digital biomarkers market forecast
- Digital biomarkers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading digital biomarkers market vendors that include Alphabet Inc., Altoida Inc, Aural Analytics Inc, Brainomix Ltd., Chugai Pharmaceutical Co. Ltd., Clinical Ink Inc., Empatica Inc. , eResearchTechnology GmbH, EVOCAL Health GmbH, F. Hoffmann La Roche Ltd., IMVARIA Inc., Invitrace, IQVIA Holdings Inc., IXICO plc, Koneksa Health Inc., Neurotrack Technologies Inc., PureTech Health Plc, Science Group Plc., VivoSense Inc., and APPLICARE.AI. Also, the digital biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.